Director-screenwriter Luo Jian discusses her short film, which is one of four backed by Film4 at the BFI London Film Festival ...

The Grammy Museum has announced an imminent performance by Southern rock troubadours, Little Feat. The one-off live show will ...

Mark Wenner, the lead singer and harmonica player of The Nighthawks, shares insights on the band's roots in blues music and ...

Twenty-eight Big Brother houseguests have expected the unexpected, secured their safety with competition wins, lied, schemed ...

A handful of other Warriors will be storylines of their own, but as the preseason begins a few already have gone under the radar. Here are three Warriors ... “He just looks a little bouncier, a little ...

Several charming buildings line a quiet street in downtown New Windsor, New York. - Daniel Case / Wikimedia Commons New Windsor is just 55 miles north of New York City, making it an easy trip by train ...

The Athletics pitching staff wasn't nearly as bad as many fans would believe, based off of their cumulative season stats. But at the same time, they could use a couple of fresh faces to provide ...

The countdown to the Arizona Fall League stands at five days. This year's Fall League campaign begins Monday with Scottsdale hosting Peoria at 6:30 p.m. local time (9:30 p.m. ET). We get excited about ...

In this article, we will take a look at under-the-radar dividend stocks benefiting from AI. These days, Artificial Intelligence, or AI, is the hottest theme on Wall Street, but the attention usually ...

Axsome Therapeutics' lineup already has strong momentum, and things will get better as it earns new approvals. Exelixis has found tremendous success with Cabometyx and is already looking for its ...

Every investor wants to outperform the market, but it's a challenging feat to achieve. That's why few manage to do it consistently over long periods. What's the best approach to take? Day trading is ...

Axsome Therapeutics' lineup already has strong momentum, and things will get better as it earns new approvals. Exelixis has found tremendous success with Cabometyx and is already looking for its ...